Significance, by Wilcoxon-Rank test, of perphenazine-treated animals paired with oophorectomy-alone group for each conversion was: *, not significant; t, P<O omy showed significantly higher metabolism of testosterone than tumours from rats subjected to oophorectomy alone. In all tumours, irrespective of the animal group from which they were derived, the major metabolites of testosterone were 5a-dihydrotestosterone and 5a-androstanediol. Although the mean conversions into both metabolites were greater in tumours from animals given perphenazine, the differences from the oophorectomy alone-group were not significant.
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The present results contrast with effects in intact animals where perphenazine, although producing a similar elevation in plasma prolactin values, stimulates tumour growth and causes a highly significant increase in tumour 5a-reduction of testosterone (Buchan et al., 1976) .
In summary, perphenazine failed to reproduce, in animals deprived of ovarian hormones, the marked stimulatory effects on mammary-tumour growth and steroid metabolism that it produces in endocrine-intact animals. Metabolites of oestriol in rat bile have been identified that exhibit a 17~-hydroxy-16-oxo structure (Nambara et al., 1974) . This finding was confirmed in perfusion experiments with isolated rat livers (Weber et al., 1977) . Since it is known that the kidney is involved not only in the excretion of steroid hormones but also in their intermediary metabolism, we decided to study the metabolic fate of oestrioI in the isolated perfused kidney of the rat.
[6,7-3H,]Oestriol (5.9 nmol/ml; specific radioactivity 22.1 pCi/pmol) was dissolved in l5Oml of perfusion medium; the purity of the steroid was checked by t.l.c., g.1.c. and high-pressure liquid chromatography. Kidneys of male Wistar rats (280-3OOg) were cyclically perfused for 30min at 28°C [for details of the perfusion technique, see Holler et al. (1976a) l. After perfusion, kidney homogenate, perfusion medium and urine were worked-up as described previously (Holler et al., 19766, 19776) . Systems for t.1.c. were similar to those described previously (Holler et al., 19776) ; before loading, plates were 572nd MEETING, LONDON Table 1 . Distribution of radioactivity (%) after perfusion of [6, oestrioI through isolated rat kidney Perfused radioactivity = 100%. Values are m e a n s f s n (n = 6). impregnated with 2,6-bis(l,l-dimethylethyl)-4-methylphenol (Ionol, Deutsche Shell) as antioxidant. Before the perfusion the system was carefully cleaned to prevent bacterial contamination. It was flushed with a disinfectant (Incidin, Henkel, Diisseldorf), sterile water, ~M-HCI and ethanol/water (7:3, v/v) for 5h. In addition, a sterile filter (pore size 0.22pm; Millipore, Neu-Isenburg) was put into the perfusion system. Immediately before starting organ perfusion, the system was flushed with sterile Ringer solution. A sample was taken and examined for bacterial contamination; in none of the samples were bacteria found. The perfused kidney metabolized oestriol in different ways. Most of the steroid conjugates (glucuronides and sulphates) were found in perfusion medium ; the distribution of radioactivity between kidney tissue, perfusion medium and urine is shown in Table 1 . The conjugates were separated from each other and hydrolysed either by 8-glucuronidase (EC 3.2.1.31) and solvolysis, or by arylsulphatase (EC 3.1.6.1) (Holler et al., 19766, 19776) . The steroids liberated by hydrolysis were characterised by t.1.c. Two main aglycones were found: oestriol and smaller amounts of a steroid with an additional hydroxyl group (tetrol).
Distribution of radioactivity (%)
The fraction of the unconjugated oestrogens that comprised about 90% of the perfused radioactivity contained mainly oestriol. About &8 % of this fraction, found in perfusion medium and kidney tissue, contained substances which were less polar than oestriol. Four metabolites (I-IV) were formed. Metabolite I was characterized by t.1.c. and g.1.c. as a substance which behaved like 16-epioestriol. Metabolite I1 had the same RF values in different t.1.c. systems as did 16a-hydroxyoestrone and 16-0x0-oestradiol-178 respectively. The metabolite was treated with NaBH,; the reduction products were identified by t.1.c. as 16-epioestriol (about 60 %) and oestrioI(40%). This result indicates that metabolite I1 is 16-oxo-oestradiol-17/I. Metabolite 111 showed the same RF values on t.1.c. as did oestrone. No changes in its chromatographic behaviour were detected after incubation with carboxylesterase (EC 3.1.1.1) or after refluxing it with acetic acid, followed by hydrolysis (Fishman & Biggerstaff, 1958) . After treatment with NaBH, or a 17-hydroxy steroid dehydrogenase preparation (EC 1.1.1.51), a product was obtained that on t.1.c. had the same R , values as did oestradiol-17/3. After we had proved that metabolite 111 was not identical with an oestrogen acetate or a 16,17-epoxide, the question arose as to whether it was oestrone or the corresponding isomer 3-hydroxyoestra[l,3,5( IO)trien-16-one). The substance was methylated as described by Brown (1955) and submitted to mass spectrometry and radio-g.1.c. When compared with authentic 3-methoxyoestra-l,3,5(10)trien-17-one and 3-methoxyoestra-1,3,5(10)trien-16-one, the methylated metabolite 111 was identified as 3-methoxyoestrone. In perfusion medium and kidney tissue, metabolite 111 comprised about 2-3 % of the perfused radioactivity. Metabolite IV was found in very small amounts and tentatively characterized by t.1.c.; its RF values were similar to those of 2-methoxyoestrone or oestra-l,3,5( lo), 16-tetraen-3-01 respectively. In 1960, King demonstrated a 16-hydroxy steroid dehydrogenase in rat kidney after incubation of oestriol with rat kidney homogenate, 16-epioestriol and 16-0x0-oestradiol-17fi were found. This finding is in good agreement with our results.
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The metabolite with four hydroxyl groups that was found in the fraction of the conjugated oestrogens may be identical with 2-hydroxyoestriol; in fact, perfusions of oestrone sulphate through rat kidney showed that in that organ appreciable amounts of oestrone are converted into 2-hydroxylated oestrogens (Holler et al., 1977~) .
The mechanism by which oestrone is formed from oestriol is still unknown. It may be speculated that oestriol is dehydrogenated with the oxygen remaining in position 17.
Final identification of metabolite IV may perhaps contribute to the elucidation of the reaction.
The present report is the first description of the formation of oestrone from oestriol in a mammalian organ. Linear peptides containing less than 100 amino acid residues, in general, show little ordered structure in aqueous solution unless well braced with disulphide bridges. At the physiological receptor, however, flexible peptides should be induced by the receptor environment into the appropriate conformation to stimulate a biological response. The receptor conformation is therefore fundamental to an understanding of peptidehormone pharmacology, but as yet is inaccessible to direct experimental study. This paper describes the use of an empirical approach to predict hormone conformation at the receptor and proposes the areas of the peptide sequence important for receptor interaction to be in well-defined conformations which allow maximal transfer of information between hormone and receptor via the high-information-content side chains of tryptophan, tyrosine, cystine, phenylalanine and methionine.
The structure assumed by a peptide hormone on receptor binding is induced by the proteinaceous environment of the exposed surface of the receptor. When bound to the receptor the hormone would be subject to the same conformational constraints as any other region of a protein molecule, hence the empirical methods of protein-structure prediction should be equally valid for predicting the conformation of peptides when bound to the receptor. Fig. 1 shows the predicted conformations for 19 peptides at their respective physiological receptors. The predictions are obtained by using the procedures of Chou & Fasman (1974a,b) with improved probabilities (Chou et a[. , 1975; Fasman eta/., 1976) . In most cases, the total sequence of a peptide hormone is not essential for receptor affinity and biological activity: a region of the sequence can usually be assigned as an 'active core', i.e. a minimum sequence that produces a biological response. Ordered secondary structure is predicted for 77 % of the total peptide sequences considered.
More significantly, all of the 'active core' regions are predicted to assume ordered conformation at the receptor. The binding of the 'active core' regions to the receptor is
